-
公开(公告)号:US07241568B2
公开(公告)日:2007-07-10
申请号:US10434469
申请日:2003-05-09
申请人: Nobuo Hanai , Motoo Yamasaki , Akiko Furuya , Akira Tanaka , Kenya Shitara , Naoki Shimada , Kazuyasu Nakamura , Maiko Hirota
发明人: Nobuo Hanai , Motoo Yamasaki , Akiko Furuya , Akira Tanaka , Kenya Shitara , Naoki Shimada , Kazuyasu Nakamura , Maiko Hirota
IPC分类号: A61K39/00 , A61K39/395
CPC分类号: C07K16/22
摘要: A method for preventing or treating a disease, comprising administering to human or animal in need of such prevention or treatment an effective amount of a monoclonal antibody which specifically binds to FGF-8 and inhibits FGF-8 activity.
摘要翻译: 一种预防或治疗疾病的方法,包括向需要这种预防或治疗的人或动物施用有效量的特异性结合FGF-8并抑制FGF-8活性的单克隆抗体。
-
2.
公开(公告)号:US08632996B2
公开(公告)日:2014-01-21
申请号:US13492465
申请日:2012-06-08
申请人: Kenya Shitara , Nobuo Hanai , Emi Shoji , Mikiko Sakurada , Akiko Furuya , Kazuyasu Nakamura , Rinpei Niwa , Kenji Shibata , Motoo Yamasaki
发明人: Kenya Shitara , Nobuo Hanai , Emi Shoji , Mikiko Sakurada , Akiko Furuya , Kazuyasu Nakamura , Rinpei Niwa , Kenji Shibata , Motoo Yamasaki
IPC分类号: C12P21/00
CPC分类号: G01N33/543 , A61K2039/505 , C07K16/2866 , C07K2317/24 , C07K2317/565 , C07K2317/732 , C07K2319/00 , G01N2333/78
摘要: A recombinant antibody or the antibody fragment thereof which specifically reacts with an extracellular domain of human CCR4; a DNA which encodes the recombinant antibody or the antibody fragment thereof; a method for producing the recombinant antibody or the antibody fragment thereof; a method for immunologically detecting CCR4, a method for immunologically detecting a cell which expressed CCR4 on the cell surface, a method for depleting a cell which expresses CCR4 on the cell surface, and a method for inhibiting production of Th2 cytokine, which comprise using the recombinant antibody according or antibody fragment thereof; a therapeutic or diagnostic agent for Th2-mediated immune diseases; and a therapeutic or diagnostic agent for a blood cancer.
摘要翻译: 与人CCR4的细胞外结构域特异性反应的重组抗体或其抗体片段; 编码重组抗体或其抗体片段的DNA; 制备重组抗体或其抗体片段的方法; 用于免疫学检测CCR4的方法,用于免疫检测在细胞表面上表达CCR4的细胞的方法,用于在细胞表面上表达CCR4的细胞消耗的方法,以及抑制Th2细胞因子产生的方法,其包括使用 重组抗体或其抗体片段; Th2介导的免疫疾病的治疗或诊断剂; 和用于血液癌的治疗或诊断剂。
-
公开(公告)号:US08197814B2
公开(公告)日:2012-06-12
申请号:US12684651
申请日:2010-01-08
申请人: Kenya Shitara , Nobuo Hanai , Emi Shoji , Mikiko Sakurada , Akiko Furuya , Kazuyasu Nakamura , Rinpei Niwa , Kenji Shibata , Motoo Yamasaki
发明人: Kenya Shitara , Nobuo Hanai , Emi Shoji , Mikiko Sakurada , Akiko Furuya , Kazuyasu Nakamura , Rinpei Niwa , Kenji Shibata , Motoo Yamasaki
IPC分类号: A61K39/395
CPC分类号: G01N33/543 , A61K2039/505 , C07K16/2866 , C07K2317/24 , C07K2317/565 , C07K2317/732 , C07K2319/00 , G01N2333/78
摘要: A recombinant antibody or the antibody fragment thereof which specifically reacts with an extracellular domain of human CCR4; a DNA which encodes the recombinant antibody or the antibody fragment thereof; a method for producing the recombinant antibody or the antibody fragment thereof; a method for immunologically detecting CCR4, a method for immunologically detecting a cell which expressed CCR4 on the cell surface, a method for depleting a cell which expresses CCR4 on the cell surface, and a method for inhibiting production of Th2 cytokine, which comprise using the recombinant antibody according or antibody fragment thereof; a therapeutic or diagnostic agent for Th2-mediated immune diseases; and a therapeutic or diagnostic agent for a blood cancer.
摘要翻译: 与人CCR4的细胞外结构域特异性反应的重组抗体或其抗体片段; 编码重组抗体或其抗体片段的DNA; 制备重组抗体或其抗体片段的方法; 用于免疫学检测CCR4的方法,用于免疫检测在细胞表面上表达CCR4的细胞的方法,用于在细胞表面上表达CCR4的细胞消耗的方法,以及抑制Th2细胞因子产生的方法,其包括使用 重组抗体或其抗体片段; Th2介导的免疫疾病的治疗或诊断剂; 和用于血液癌的治疗或诊断剂。
-
公开(公告)号:US06989145B2
公开(公告)日:2006-01-24
申请号:US09796744
申请日:2001-03-02
申请人: Kenya Shitara , Nobuo Hanai , Emi Shoji , Mikiko Sakurada , Akiko Furuya , Kazuyasu Nakamura , Rinpei Niwa , Kenji Shibata , Motoo Yamasaki
发明人: Kenya Shitara , Nobuo Hanai , Emi Shoji , Mikiko Sakurada , Akiko Furuya , Kazuyasu Nakamura , Rinpei Niwa , Kenji Shibata , Motoo Yamasaki
CPC分类号: G01N33/543 , A61K2039/505 , C07K16/2866 , C07K2317/24 , C07K2317/565 , C07K2317/732 , C07K2319/00 , G01N2333/78
摘要: A recombinant antibody or the antibody fragment thereof which specifically reacts with an extracellular domain of human CCR4; a DNA which encodes the recombinant antibody or the antibody fragment thereof; a method for producing the recombinant antibody or the antibody fragment thereof; a method for immunologically detecting CCR4, a method for immunologically detecting a cell which expressed CCR4 on the cell surface, a method for depleting a cell which expresses CCR4 on the cell surface, and a method for inhibiting production of Th2 cytokine, which comprise using the recombinant antibody according or antibody fragment thereof; a therapeutic or diagnostic agent for Th2-mediated immune diseases; and a therapeutic or diagnostic agent for a blood cancer.
摘要翻译: 与人CCR4的细胞外结构域特异性反应的重组抗体或其抗体片段; 编码重组抗体或其抗体片段的DNA; 制备重组抗体或其抗体片段的方法; 用于免疫学检测CCR4的方法,用于免疫检测在细胞表面上表达CCR4的细胞的方法,用于在细胞表面上表达CCR4的细胞消耗的方法,以及抑制Th2细胞因子产生的方法,其包括使用 重组抗体或其抗体片段; Th2介导的免疫疾病的治疗或诊断剂; 和用于血液癌的治疗或诊断剂。
-
公开(公告)号:US20100221178A1
公开(公告)日:2010-09-02
申请号:US12684651
申请日:2010-01-08
申请人: Kenya SHITARA , Nobuo Hanai , Emi Shoji , Mikiko Sakurada , Akiko Furuya , Kazuyasu Nakamura , Rinpei Niwa , Kenji Shibata , Motoo Yamasaki
发明人: Kenya SHITARA , Nobuo Hanai , Emi Shoji , Mikiko Sakurada , Akiko Furuya , Kazuyasu Nakamura , Rinpei Niwa , Kenji Shibata , Motoo Yamasaki
IPC分类号: A61K39/395 , A61K51/10 , A61P37/00
CPC分类号: G01N33/543 , A61K2039/505 , C07K16/2866 , C07K2317/24 , C07K2317/565 , C07K2317/732 , C07K2319/00 , G01N2333/78
摘要: A recombinant antibody or the antibody fragment thereof which specifically reacts with an extracellular domain of human CCR4; a DNA which encodes the recombinant antibody or the antibody fragment thereof; a method for producing the recombinant antibody or the antibody fragment thereof; a method for immunologically detecting CCR4, a method for immunologically detecting a cell which expressed CCR4 on the cell surface, a method for depleting a cell which expresses CCR4 on the cell surface, and a method for inhibiting production of Th2 cytokine, which comprise using the recombinant antibody according or antibody fragment thereof; a therapeutic or diagnostic agent for Th2-mediated immune diseases; and a therapeutic or diagnostic agent for a blood cancer.
摘要翻译: 与人CCR4的细胞外结构域特异性反应的重组抗体或其抗体片段; 编码重组抗体或其抗体片段的DNA; 制备重组抗体或其抗体片段的方法; 用于免疫学检测CCR4的方法,用于免疫检测在细胞表面上表达CCR4的细胞的方法,用于在细胞表面上表达CCR4的细胞消耗的方法,以及抑制Th2细胞因子产生的方法,其包括使用 重组抗体或其抗体片段; Th2介导的免疫疾病的治疗或诊断剂; 和用于血液癌的治疗或诊断剂。
-
公开(公告)号:US07666418B2
公开(公告)日:2010-02-23
申请号:US11094718
申请日:2005-03-31
申请人: Kenya Shitara , Nobuo Hanai , Emi Shoji , Mikiko Sakurada , Akiko Furuya , Kazuyasu Nakamura , Rinpei Niwa , Kenji Shibata , Motoo Yamasaki
发明人: Kenya Shitara , Nobuo Hanai , Emi Shoji , Mikiko Sakurada , Akiko Furuya , Kazuyasu Nakamura , Rinpei Niwa , Kenji Shibata , Motoo Yamasaki
IPC分类号: A61K39/395 , A61K39/00
CPC分类号: G01N33/543 , A61K2039/505 , C07K16/2866 , C07K2317/24 , C07K2317/565 , C07K2317/732 , C07K2319/00 , G01N2333/78
摘要: A recombinant antibody or the antibody fragment thereof which specifically reacts with an extracellular domain of human CCR4; a DNA which encodes the recombinant antibody or the antibody fragment thereof; a method for producing the recombinant antibody or the antibody fragment thereof; a method for immunologically detecting CCR4, a method for immunologically detecting a cell which expressed CCR4 on the cell surface, a method for depleting a cell which expresses CCR4 on the cell surface, and a method for inhibiting production of Th2 cytokine, which comprise using the recombinant antibody according or antibody fragment thereof; a therapeutic or diagnostic agent for Th2-mediated immune diseases; and a therapeutic or diagnostic agent for a blood cancer.
摘要翻译: 与人CCR4的细胞外结构域特异性反应的重组抗体或其抗体片段; 编码重组抗体或其抗体片段的DNA; 制备重组抗体或其抗体片段的方法; 用于免疫学检测CCR4的方法,用于免疫检测在细胞表面上表达CCR4的细胞的方法,用于在细胞表面上表达CCR4的细胞消耗的方法,以及抑制Th2细胞因子产生的方法,其包括使用 重组抗体或其抗体片段; Th2介导的免疫疾病的治疗或诊断剂; 和用于血液癌的治疗或诊断剂。
-
公开(公告)号:US20050187380A1
公开(公告)日:2005-08-25
申请号:US11094718
申请日:2005-03-31
申请人: Kenya Shitara , Nobuo Hanai , Emi Shoji , Mikiko Sakurada , Akiko Furuya , Kazuyasu Nakamura , Rinpei Niwa , Kenji Shibata , Motoo Yamasaki
发明人: Kenya Shitara , Nobuo Hanai , Emi Shoji , Mikiko Sakurada , Akiko Furuya , Kazuyasu Nakamura , Rinpei Niwa , Kenji Shibata , Motoo Yamasaki
IPC分类号: A61P11/06 , A61P17/00 , A61P27/14 , A61P37/08 , C07K16/28 , C12N15/13 , C12P21/08 , G01N33/543 , C07H21/04 , C07K14/28 , C12N5/06
CPC分类号: G01N33/543 , A61K2039/505 , C07K16/2866 , C07K2317/24 , C07K2317/565 , C07K2317/732 , C07K2319/00 , G01N2333/78
摘要: A recombinant antibody or the antibody fragment thereof which specifically reacts with an extracellular domain of human CCR4; a DNA which encodes the recombinant antibody or the antibody fragment thereof; a method for producing the recombinant antibody or the antibody fragment thereof; a method for immunologically detecting CCR4, a method for immunologically detecting a cell which expressed CCR4 on the cell surface, a method for depleting a cell which expresses CCR4 on the cell surface, and a method for inhibiting production of Th2 cytokine, which comprise using the recombinant antibody according or antibody fragment thereof; a therapeutic or diagnostic agent for Th2-mediated immune diseases; and a therapeutic or diagnostic agent for a blood cancer.
摘要翻译: 与人CCR4的细胞外结构域特异性反应的重组抗体或其抗体片段; 编码重组抗体或其抗体片段的DNA; 制备重组抗体或其抗体片段的方法; 用于免疫学检测CCR4的方法,用于免疫检测在细胞表面上表达CCR4的细胞的方法,用于在细胞表面上表达CCR4的细胞消耗的方法,以及抑制Th2细胞因子产生的方法,其包括使用 重组抗体或其抗体片段; Th2介导的免疫疾病的治疗或诊断剂; 和用于血液癌的治疗或诊断剂。
-
公开(公告)号:US07438911B2
公开(公告)日:2008-10-21
申请号:US10513148
申请日:2003-04-30
申请人: Kenya Shitara , Kazuyasu Nakamura , Akiko Furuya , Rinpei Niwa , Yuji Ohki , Nobuo Hanai
发明人: Kenya Shitara , Kazuyasu Nakamura , Akiko Furuya , Rinpei Niwa , Yuji Ohki , Nobuo Hanai
CPC分类号: C07K16/22 , C07K2317/24 , C07K2317/33 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92
摘要: For the effective treatment of diseases such as cancer in which hIGF participates, there have been desired to be developed antibodies which strongly bind to both factors hIGF-I and hIGF-II and inhibit their functions and fragments of these antibodies. The present invention provides antibodies which have the ability to specifically bind to human IGF-I and IGF-II to thereby inhibit the functions of human IGF-I and IGF-II and have binding activity with a binding constant of 5×109 M−1 or more measured with a biosensor BIACORE. In addition, the present invention provides diagnostics, preventives and remedies for an hIGF-mediated disease and a disease showing pathological progressing due to abnormally promoted hIGF production, which use said antibodies.
摘要翻译: 为了有效治疗诸如hIGF参与的癌症的疾病,期望开发出与hIGF-1和hIGF-II两者强烈结合并抑制其功能和这些抗体片段的抗体。 本发明提供具有特异性结合人IGF-I和IGF-II从而抑制人IGF-I和IGF-II的功能并具有结合常数为5×10 9的结合活性的抗体, 或者用生物传感器BIACORE测量的更高/更高。 此外,本发明提供了hIGF介导的疾病的诊断,预防措施和补救措施以及由于异常促进的hIGF产生导致使用所述抗体的病理进展的疾病。
-
公开(公告)号:US06310184B1
公开(公告)日:2001-10-30
申请号:US09326590
申请日:1999-06-07
申请人: Nobuo Hanai , Motoo Yamasaki , Akiko Furuya , Akira Tanaka
发明人: Nobuo Hanai , Motoo Yamasaki , Akiko Furuya , Akira Tanaka
IPC分类号: C07K1600
CPC分类号: C23C14/30 , C07K16/22 , C07K2317/73 , C23C26/00 , G02B1/105
摘要: Described is a monoclonal antibody capable of specifically binding to fibroblast growth factor-8 (FGF-8) which is related to growth factors of hormone-dependent tumor cells such as prostatic cancer and breast cancer, and inhibits the FGF-8 activity. The monoclonal antibody is useful in analyzing the role and biological function of FGF-8 in hormone-dependent tumor cells such as prostatic cancer and breast cancer and can be beneficial in the treatment of these cancers.
摘要翻译: 描述了能够特异性结合成纤维细胞生长因子-8(FGF-8)的单克隆抗体,其与激素依赖性肿瘤细胞如前列腺癌和乳腺癌的生长因子相关,并且抑制FGF-8活性。 单克隆抗体可用于分析FGF-8在激素依赖性肿瘤细胞如前列腺癌和乳腺癌中的作用和生物学功能,可有助于治疗这些癌症。
-
公开(公告)号:US5952472A
公开(公告)日:1999-09-14
申请号:US832236
申请日:1997-04-03
申请人: Nobuo Hanai , Motoo Yamasaki , Akiko Furuya , Akira Tanaka
发明人: Nobuo Hanai , Motoo Yamasaki , Akiko Furuya , Akira Tanaka
IPC分类号: G01N33/53 , A61K39/395 , A61P35/00 , C07H21/04 , C07K16/00 , C07K16/22 , C07K19/00 , C12N5/10 , C12N5/20 , C12N15/02 , C12P21/08 , C12R1/91 , C23C14/30 , C23C26/00 , C23C28/00 , C23C28/02 , G01N33/574 , G01N33/577 , C12N5/06
CPC分类号: C23C14/30 , C07K16/22 , C23C26/00 , G02B1/105 , C07K2317/73
摘要: Described is a monoclonal antibody capable of specifically binding to fibroblast growth factor-8 (FGF-8) which is related to growth factors of hormone-dependent tumor cells such as prostatic cancer and breast cancer, and inhibits the FGF-8 activity. The monoclonal antibody is useful in analyzing the role and biological function of FGF-8 in hormone-dependent tumor cells such as prostatic cancer and breast cancer and can be beneficial in the treatment of these cancers.
-
-
-
-
-
-
-
-
-